← Browse by Condition
Medical Condition

antibody

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT06482801 Phase 2
Recruiting

Checkpoint Inhibitor Combinations Therapy as First Line for HCC Via IT

Enrollment
90 pts
Location
China
Sponsor
Second Affiliated Hospital of ...
View Trial →